[go: up one dir, main page]

AR082436A1 - USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS - Google Patents

USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS

Info

Publication number
AR082436A1
AR082436A1 ARP110102772A ARP110102772A AR082436A1 AR 082436 A1 AR082436 A1 AR 082436A1 AR P110102772 A ARP110102772 A AR P110102772A AR P110102772 A ARP110102772 A AR P110102772A AR 082436 A1 AR082436 A1 AR 082436A1
Authority
AR
Argentina
Prior art keywords
teriflunomide
multiple sclerosis
treat multiple
treat
treatment
Prior art date
Application number
ARP110102772A
Other languages
Spanish (es)
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of AR082436A1 publication Critical patent/AR082436A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Uso de teriflunomida para el tratamiento de la Esclerosis Múltiple (EM) y para tratar los riesgos asociados con el uso de teriflunomida.Use of teriflunomide for the treatment of Multiple Sclerosis (MS) and to treat the risks associated with the use of teriflunomide.

ARP110102772A 2010-08-02 2011-08-01 USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS AR082436A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36978010P 2010-08-02 2010-08-02
US36977910P 2010-08-02 2010-08-02
US38937510P 2010-10-04 2010-10-04
US201061424717P 2010-12-20 2010-12-20

Publications (1)

Publication Number Publication Date
AR082436A1 true AR082436A1 (en) 2012-12-05

Family

ID=45559773

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102772A AR082436A1 (en) 2010-08-02 2011-08-01 USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS

Country Status (4)

Country Link
EP (1) EP2600861A1 (en)
AR (1) AR082436A1 (en)
UY (1) UY33542A (en)
WO (1) WO2012018704A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2762135A1 (en) * 2013-02-04 2014-08-06 Sanofi Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
RS64541B1 (en) 2016-08-15 2023-09-29 Novartis Ag Regimens and methods of treating multiple sclerosis using ofatumumab
JOP20190207A1 (en) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd Pharmaceutical combination comprising ponesimod
EP4682171A2 (en) * 2020-04-09 2026-01-21 Novartis AG Ofatumumab for treating ms while maintaining serum igg

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268382A (en) 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis

Also Published As

Publication number Publication date
WO2012018704A1 (en) 2012-02-09
EP2600861A1 (en) 2013-06-12
UY33542A (en) 2012-02-29

Similar Documents

Publication Publication Date Title
ECSP24031979A (en) THERAPEUTIC ACTIVE COMPOUNDS AND THEIR METHODS OF USE
MX2015003140A (en) ENZALUTAMIDE FORMULATIONS.
ECSP15026557A (en) COMPOUNDS AND THEIR METHODS OF USE
ECSP14017269A (en) COMPOUNDS TO TREAT SPINAL MUSCULAR ATROPHY
GT201400147A (en) PYRIMIDINES AND FUSIONATED TRIAZINS REPLACED AND ITS USE
AR089993A1 (en) PEPTIDOMIMETIC MACROCICLES
MX2012012527A (en) CHEMICAL COMPOUNDS.
UY34395A (en) ? Multiple sclerosis treatment with the combination of Laquinimod and Fingolimod ?.
CL2012003385A1 (en) Incontinence treatment.
UY34632A (en) OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME
UY34484A (en) BENZOTIENILO-PIRROLOTRIAZINAS DISUSTITUIDAS AND ITS USES
UY34876A (en) ANTI-EGFR ANTIBODIES AND USES OF THE SAME
DOP2014000098A (en) 2-THIOPIRIMIDINONES
EA201591399A1 (en) RAPPγ AGONISTS FOR TREATMENT OF MULTIDATED SCLEROSIS
CO7350653A2 (en) Retinoids and their use
MX2014015039A (en) FBX03 INHIBITORS.
UY34315A (en) ? USE OF AN AROMATASE INHIBITOR FOR THE TREATMENT OF HYPOGONADISM AND RELATED DISEASES?
AR082436A1 (en) USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS
ECSP13012988A (en) DERIVATIVES OF TIENOPIRIMIDINE (2,3-D) AND ITS USE TO TREAT ARRITMIA
UY35823A (en) NMDA ANTAGONIST PROPHARMS
CO7121349A2 (en) Methods to treat cancer using pi3k inhibitor and mek inhibitor
AR081220A1 (en) USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY
MX2013006526A (en) Dosages of arylsulfonamide derivatives.
CR20140489A (en) USE OF 18-METIL-15B, 16B-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS IN THE TREATMENT OF MENORRAGY, AND INTRAUTERINE SYSTEMS THAT INCLUDE 18-METIL-15B, 16B-METILEN-19- NOR-20-ESPIROX-4-EN-3-ONAS FOR THE TREATMENT OF T
UA52378U (en) use of lipoflavon as agent with frigoprotective action

Legal Events

Date Code Title Description
FB Suspension of granting procedure